怎样做好甲状腺手术---艺术的追求

讲者：赵文新主任（福建医科大学附属协和医院甲状腺外科）讲题：怎样做好甲状腺手术---艺术的追求

NCCN指南解析

指南那么长，怎么指导临床？每次的更新，依据又是什么？有疑惑吗？别着急！壹生大学邀请了临床一线的专家们，将指南拆分详解，带给您最贴近临床的指南解析。

中国肝癌领导力论坛精粹

中国肝癌领导力论坛暨拜万戈肝癌上市会于2018年3月18日在上海隆重举办

05 Robert LaCaze-拜耳全球肿瘤研发及业务新方向

Robert LaCaze 总裁拜耳全球肿瘤事业部总裁Robert LaCaze is a senior bio-pharmaceutical executive with more than 28 years of experience in the industry. Throughout his career he has served in multiple operational and strategic roles involving the US, EU, China and Japan.Mr. LaCaze joined Bayer Pharmaceuticals in October 2015 and currently serves as the Executive Vice President and Head of the Oncology Strategic Business Unit (SBU). The Oncology SBU is responsible for all strategy in Bayer’s Oncology Business and consists of: Clinical Development, Regulatory Affairs, Strategic Medical Affairs, Strategic Marketing and Commercialization, Oncology Market Access and Clinical Operations. He is also a member of Bayer’s Pharmaceutical Executive Committee.Prior to joining Bayer, Mr. LaCaze spent over 25 years with Bristol Myers Squibb serving in multiple roles including his two most recent roles of Senior Vice President and Head of Product and Portfolio Strategy for Worldwide Commercialization and Senior Vice President, Global Oncology Commercialization in which he was responsible, with his R&D counterpart, for setting the vision and strategy for the Immuno-Oncology (I-O) franchise. He oversaw the early strategy for Nivolumab and lead the Global Launch of Ipilimumab BMS’s first I-O drug and the Global launch of BMS’s first target therapy, Dasatinib. Both of which have achieved more than $1B in annual sales.Mr LaCaze is a member of AACR and also serves as a member of the College of Business Advisory Board for Louisiana Tech University, his alma mater. He, his wife, and two sons reside in Robbinsville NJ.

北肿胰腺癌及神经内分泌肿瘤交流

李囡--胰腺net核医学靶向诊疗 王湛博--胰腺癌组织学病理及分子分型的学习与思考李洁--pNEN的诊断和治疗金克敏--胰腺神经内分泌肿瘤的外科治疗谷满仓--分子靶向细胞周期依赖蛋白激酶（CDKs）在胰腺癌治疗中的进展周军--进展期胰腺癌的化疗选择

结直肠癌治疗大师班

【跟我学“坎贝尔”】之 尿路碎石

北肿结直肠肿瘤论坛

本次系列视频，主要有以下几个专题：1、直肠癌新辅助治疗/等待观察/保留器官手术2、肝转移局部治疗3、造口伤口护理4、结直肠癌手术并发症处理和预防5、肝外转移，如何处理？6、围手术期康复及生活质量评价7、遗传性肿瘤8、中青年消化肿瘤精英论坛9、直肠癌新辅助治疗后的手术10、症状管理、支持和姑息治疗11、结直肠癌姑息化疗/免疫治疗进展/转化治疗分别邀请了行业内的精英做报告，内容详实、案例丰富，是了解行业进展、前沿知识、经验学习不容错过的优秀教材！

腹腔镜泌尿外科之并发症的处理（1）

随着读书的深入，内容越来越精彩。从腹腔镜的操作系统、术中人员的站位到术前准备，如今细化到止血夹的使用，《坎贝尔-沃尔什泌尿外科学》进行详细的讲述。操作过程中有哪些不规范？腹腔镜术后并发症该怎么处理？点开视频一探究竟吧！北京大学大学第三医院泌尿外科经过几代人的不懈努力，已发展成为集临床、科研、教学于一体，国际知名、国内领先的泌尿外科中心，年住院手术量3657台，男科2102台，门诊手术量近4000台。是卫生部国家临床重点专科，教育部国家级重点学科，还是院级重点学科。

2017淋巴瘤诊治“全观察”

淋巴瘤是起源于淋巴造血系统的恶性肿瘤，具有高度异质性。治疗方法主要有化疗、放疗、生物治疗、手术治疗等，治疗效果越来越好。辞旧迎新之际，国内淋巴瘤领域一众专家分享了不同类型淋巴瘤2017那些最值得关注的治疗进展。